353 filings
Page 7 of 18
8-K
ib5f2uiehffigxhkr
7 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
sv6hkoepz2w
16 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
qqe4tm5p0yqby 6qlh
12 Jan 16
Enrollment for Phase 2B Interim Analysis of Efficacy Data Expected by Year-End 2016
12:00am
8-K
a6qin8
12 Nov 15
ARCA Biopharma announces third quarter 2015 financial results and provides business update
12:00am
8-K
wv4 7u60m
9 Sep 15
Other Events
12:00am
8-K
pr4d4ys0cqm19dy
3 Sep 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
qztzbxh
11 Aug 15
ARCA Biopharma announces Second quarter 2015 operating results and provides Update on recent accomplishments
12:00am
8-K
u1d 92fzg
16 Jul 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
16nzxow xpd5t5e96m
23 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
wfmv3
11 Jun 15
ARCA Biopharma Announces $37 Million private placement
12:00am
8-K
pc331dfvg
5 Jun 15
Other Events
12:00am
8-K
63061bki
13 Apr 15
Other Events
12:00am
8-K
73jqe8vi icq0jyga
16 Mar 15
ARCA Biopharma provides genetic-af clinical trial update
12:00am
8-K
pwnuvwjmx3m4krs
23 Feb 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
135juwj6cwe
17 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
qjiz8
4 Feb 15
Other Events
12:00am
8-K
js6scx2zw2yla0w4j11k
11 Dec 14
Arca Biopharma Announces Activation of First Canadian
12:00am
8-K
mnmsom8iiqs
10 Dec 14
Arca Biopharma Receives Fda Orphan Drug Designation for RNAPC2 As a Potential Treatment for Ebola
12:00am
8-K
m9nxzj1lzywsd21
1 Dec 14
Arca Biopharma Announces Management Transitions
12:00am
8-K
7rblylqk
18 Aug 14
Arca Biopharma Announces Health Canada Acceptance of Genetic-af Clinical Trial Application
12:00am